TITLE

Widespread adoption of Robot-Assisted Cancer Surgery to remove the prostate

PUB. DATE
September 2014
SOURCE
Pulse International;9/15/2014, Vol. 15 Issue 17, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a study at Harvard Medical School, the Dana-Farber Cancer Institute and Brigham and Women's Hospital published in "British Journal of Urology International" which indicated the use of robotic-assisted radical prostatectomy surgical procedure for patients with prostate cancer.
ACCESSION #
99291877

 

Related Articles

  • British Journal of Urology Intl: Prostate cancer treatment regret is 52% higher in men with cardiovascular disease.  // Biomedical Market Newsletter;7/19/2012, Vol. 21, p1 

    The article focuses on a study by Harvard Medical School which shows that prostate cancer patients with heart disease are 52 percent likely to regret treatment for the disease than those without heart health problems.

  • Five-Year RARP Outcomes Are 'Highly Satisfactory,' Researchers Conclude.  // Renal & Urology News;May2011, Vol. 10 Issue 5, p15 

    The article focuses on the results of the five-year oncologic outcomes of robot-assisted radical prostatectomy (RARP) for patients with organ-confined localized prostate cancer (PCa) as studied by the research team led by doctor Nazareno Suardi.

  • Radiotherapy after prostatectomy increased PFS in pT3 prostate cancer. Adams, Stacey L.; Haigh, Christen; Harris, Jason; Lewis, Jay; Southall, Jen; Volansky, Rob // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p38 

    The article discusses research on the effect of radiotherapy after prostatectomy on progression-free survival (PFS) in pT3 prostate cancer patients, which references a study by J. Wiegel published in a 2009 issue of the "Journal of Clinical Oncology."

  • Impotence is not inevitable after prostate cancer treatment. McCann, Jean // JNCI: Journal of the National Cancer Institute;02/05/97, Vol. 89 Issue 3, p194 

    Focuses on prostate cancer patients' recovery of sexual functions after undergoing nerve-sparing radical prostatectomy. Surgeon D. Karl Montague's report on guidelines for the treatment of impotence or erectile dysfunction; 1996 World Meeting on Impotence; Surgical options for restoring erectile...

  • PCa Death Risk Low Despite PSM.  // Renal & Urology News;Jun2012, Vol. 11 Issue 6, p31 

    The article reports on a study which revealed that prostate cancer (PCa) patients has a positive surgical margin (PSM) in their radical prostatectomy specimen has a low risk of cancer-related death and systemic progression.

  • Short Takes.  // Renal & Urology News;Apr2010, Vol. 9 Issue 4, p9 

    The article offers news briefs related to medical research including a study on kidney cancer which less probably to develop in men whose work expose them to sunlight, another study on prostate cancer patients having prostate-cancer survival after radical prostatectomy and a study on acute...

  • Obesity Does Not Alter RALP Outcomes, Study Shows.  // Renal & Urology News;Jun2010, Vol. 9 Issue 6, p32 

    The article reports on the findings of a study regarding the association of obesity and the outcomes of robotic-assisted laparoscopic prostatectomy (RALP) in patients with prostate cancer in the U.S.

  • Metastasis-Free Interval Affects PCa Patient Survival.  // Renal & Urology News;Oct2013, Vol. 12 Issue 10, p15 

    The article reports on the study conducted by Michael T. Schweizer and colleagues at Johns Hopkins University in Baltimore which suggests that longer metastasis-free survival predicts overall survival in men who experience biochemical recurrence of prostate cancer (PCa) after radical prostatectomy.

  • The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer. Kuzgunbay, Barış; Yaycıoğlu, Özgür // Journal of Urological Surgery;Sep2015, Vol. 2 Issue 3, p120 

    High-risk prostate cancer (PCa), which is defined as PSA >20 ng/mL or Gleason Score (GS) >7 or ≥cT3a, accounts for up to 40% of newly diagnosed cases and carries a significant risk of progression and death. However, the best management approach for patients with high-risk PCa is still...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics